National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
National Research Dividend Announcement
• National Research announced a quarterly dividend of $0.12 per ordinary share which will be made payable on 2025-01-10. Ex dividend date: 2024-12-27
• National Research annual dividend for 2024 was $0.48
• National Research annual dividend for 2023 was $1.48
• National Research's trailing twelve-month (TTM) dividend yield is 2.46%
• National Research's payout ratio for the trailing twelve months (TTM) is 42.77%
• National Research's dividend growth over the last five years (2018-2023) was 5.54% year
National Research Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-27 | $0.12 | quarterly | 2025-01-10 |
2024-09-27 | $0.12 | quarterly | 2024-10-11 |
2024-06-28 | $0.12 | quarterly | 2024-07-15 |
2024-03-27 | $0.12 | quarterly | 2024-04-15 |
2023-12-28 | $0.12 | quarterly | 2024-01-12 |
2023-09-28 | $0.12 | quarterly | 2023-10-13 |
2023-09-15 | $1.00 | quarterly | 2023-09-22 |
2023-06-29 | $0.12 | quarterly | 2023-07-14 |
2023-03-30 | $0.12 | quarterly | 2023-04-14 |
2022-12-29 | $0.12 | quarterly | 2023-01-13 |
2022-09-29 | $0.24 | quarterly | 2022-10-14 |
2022-06-29 | $0.24 | quarterly | 2022-07-15 |
2022-03-30 | $0.24 | quarterly | 2022-04-15 |
2021-12-29 | $0.12 | quarterly | 2022-01-14 |
2021-09-29 | $0.12 | quarterly | 2021-10-15 |
2021-06-29 | $0.12 | quarterly | 2021-07-15 |
2021-04-16 | $0.12 | quarterly | 2021-04-27 |
2020-03-30 | $0.21 | quarterly | 2020-04-15 |
2019-12-30 | $0.21 | quarterly | 2020-01-15 |
2019-09-27 | $0.19 | quarterly | 2019-10-15 |
2019-06-27 | $0.19 | quarterly | 2019-07-15 |
2019-03-28 | $0.19 | quarterly | 2019-04-15 |
2018-12-28 | $0.69 | quarterly | 2019-01-15 |
2018-09-27 | $0.17 | quarterly | 2018-10-15 |
2018-06-28 | $0.17 | quarterly | 2018-07-13 |
2018-03-28 | $0.10 | quarterly | 2018-04-13 |
2017-12-28 | $0.10 | quarterly | 2018-01-12 |
2017-09-28 | $0.10 | quarterly | 2017-10-13 |
2017-06-28 | $0.10 | quarterly | 2017-07-14 |
2017-03-29 | $0.10 | quarterly | 2017-04-14 |
2016-12-28 | $0.10 | quarterly | 2017-01-13 |
2016-09-28 | $0.08 | quarterly | 2016-10-14 |
2016-06-28 | $0.08 | quarterly | 2016-07-15 |
2016-03-29 | $0.08 | quarterly | 2016-04-15 |
2015-12-29 | $0.36 | quarterly | 2016-01-15 |
2015-09-28 | $0.06 | quarterly | 2015-10-15 |
2015-06-26 | $0.06 | quarterly | 2015-07-15 |
2015-03-27 | $0.06 | quarterly | 2015-04-15 |
2014-12-29 | $0.06 | quarterly | 2015-01-15 |
National Research Dividend per year
National Research Dividend growth
National Research Dividend Yield
National Research current trailing twelve-month (TTM) dividend yield is 2.46%. Interested in purchasing National Research stock? Use our calculator to estimate your expected dividend yield:
National Research Financial Ratios
National Research Dividend FAQ
Other factors to consider when evaluating National Research as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy National Research stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: National Research's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, National Research publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, National Research distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from National Research are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: National Research sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, National Research distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: National Research declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of National Research's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review National Research's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.